Open AccessOvarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors
Author(s) -
Rowan Miller,
Osnat Elyashiv,
Karim El-Shakankery,
Jonathan A. Ledermann
Publication year - 2022
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s272199
Subject(s) - homologous recombination , parp inhibitor , ovarian cancer , poly adp ribose polymerase , serous fluid , biomarker , medicine , cancer , homologous chromosome , cancer research , polymerase , oncology , bioinformatics , gene , genetics , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom